You are currently on the Isle of Man version.
Looks like you are in United States.
Switch to local content?
The webinar focuses on testing the performance of AI tools, specifically a therapy planning tool (TPS) from deepeye Medical, in real-world clinical practice for treating neovascular age-related macular degeneration (nAMD). It compares the AI's performance to physician assessments and assessments under Reading-Center conditions.